Krystal Biotech, Inc. (KRYS)
271.30
-1.31
(-0.48%)
USD |
NASDAQ |
Feb 10, 10:09
Krystal Biotech Market Cap : 7.867B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.414B |
| DexCom, Inc. | 26.87B |
| Alkermes Plc | 5.754B |
| Regeneron Pharmaceuticals, Inc. | 81.47B |
| Alnylam Pharmaceuticals, Inc. | 42.65B |
Market Cap Related Metrics
| PE Ratio | 40.69 |
| PS Ratio | 21.69 |
| PEG Ratio | 0.1468 |
| Price to Book Value | 6.914 |
| Price to Free Cash Flow | 48.88 |
| Price | 271.30 |
| Earnings Yield | 2.46% |
| PEGY Ratio | 0.1468 |
| Operating PE Ratio | 51.15 |
| Normalized PE Ratio | 40.69 |